Investing in Visionary Innovation
MISSION
OphthaFund is an investment fund focused primarily on compelling technologies addressing eye disease and eye care. We bring together capital, clinical insight, industry experience and investment expertise to identify and support promising companies across stages. Our goal is to invest in technologies with the potential to improve the prevention, diagnosis and treatment of eye disease while creating long-term value for investors.
Investment Strategy
Ophthalmology is a specialized field in which clinical relevance, physician adoption, development strategy and industry relationships can materially influence the success of an emerging technology. OphthaFund combines experience in ophthalmology, healthcare, biotechnology, business and investing with a network developed across clinical, entrepreneurial and investment communities. Many opportunities reach us through long-standing relationships with clinicians, scientists, entrepreneurs, industry executives and investors.
Innovation
We identify and fund next-generation technologies that redefine clinical outcomes and patient care.
Focus
Our deep domain expertise ensures we provide the specialized guidance required for complex biotech portfolios.
Scale
We provide the capital and strategic infrastructure to scale high-potential ophthalmic ventures.
What We Invest In
We invest primarily in ophthalmology and eye care across stages and technologies, including therapeutics, medical devices, diagnostics and imaging, surgical innovation, drug delivery, digital technologies, and clinical research tools and platforms. We seek strong technology, meaningful unmet need, capable leadership and the potential for long-term clinical and investment value.
More Than Capital
When appropriate, OphthaFund provides portfolio companies with access to ophthalmic expertise, strategic guidance and industry relationships. Our involvement may include clinical development perspective, financing and commercialization strategy, advisory roles and board participation.
TECHNOLOGY • VISION • BIOTECH • TECHNOLOGY • VISION • BIOTECH • TECHNOLOGY • VISION • BIOTECH •
